Ascopiave S.p.A.
ASCOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.18 | 0.01 | -2.33 | 0.61 |
| FCF Yield | -1.86% | -0.97% | 3.18% | 2.44% |
| EV / EBITDA | 33.24 | 16.24 | 36.13 | 35.67 |
| Quality | ||||
| ROIC | 0.83% | 2.09% | 0.90% | 0.87% |
| Gross Margin | 91.62% | 91.72% | 98.55% | 93.72% |
| Cash Conversion Ratio | 1.26 | 0.26 | 3.94 | 4.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.84% | 8.77% | 7.64% | 7.79% |
| Free Cash Flow Growth | -91.90% | -127.92% | 24.46% | 9,469.27% |
| Safety | ||||
| Net Debt / EBITDA | 16.92 | 8.00 | 12.86 | 12.76 |
| Interest Coverage | 5.35 | 14.70 | 5.47 | 8.97 |
| Efficiency | ||||
| Inventory Turnover | 0.43 | 0.50 | 0.06 | 0.53 |
| Cash Conversion Cycle | -18.68 | -273.70 | -1,428.10 | -1,272.73 |